T resident memory cells in arthritis

关节炎中的T常驻记忆细胞

基本信息

  • 批准号:
    10684862
  • 负责人:
  • 金额:
    $ 42.66万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-07-01 至 2025-05-31
  • 项目状态:
    未结题

项目摘要

Project Summary Inflammatory arthritis in adults and children is often characterized by periods of quiescent activity followed by disease flares. In any individual patient, the same joints typically flare repeatedly, in a pattern that usually establishes itself early in disease and then persists for years or decades. The hypothesis of this proposal is that this “joint-specific memory” reflects the presence of T resident memory (TRM) cells, whose targeting represents a new approach to arthritis therapy. TRM are a recently-described subset of long-lived T cells, either CD8 and CD4, that develop in skin and other tissues as a response to tissue inflammation, persisting for years thereafter to provide long-lasting site-specific immunity. TRM have never been described in joints. We have now developed compelling evidence for the presence of these cells in human arthritic synovium using three orthogonal approaches: single-cell RNAseq, a novel 3-dimensional synovial culture system, coupled with cytometry by time of flight (CyTOF), and Mantra multidimensional immunofluorescence imaging. Further, we have developed or adapted three animal models to develop new murine systems optimized for the study of recurrent, joint-specific, T cell-dependent inflammatory arthritis. Building upon these preliminary data, we propose two specific aims. First, we will perform a comprehensive characterization of human synovial TRM with respect to surface phenotype, mediators, transcriptome, and metabolism to compare synovial TRM with synovial effector memory T cells and “gold standard” TRM from human skin. Second, we will use our animal models to characterize the development and persistence of TRM over time; to test the possibility that these cells can re-activate arthritis upon antigen-independent triggering as well as antigen exposure; and employ local depletion to test TRM targeting as a novel approach to durable joint-specific arthritis therapy.
项目概要 成人和儿童的炎症性关节炎通常以静止活动期为特征 随后是疾病爆发。在任何个体患者中,相同的关节通常会反复张开, 通常在疾病早期就形成这种模式,然后持续数年或数十年。这 该提案的假设是这种“关节特定记忆”反映了 T 的存在 常驻记忆(TRM)细胞,其靶向代表了关节炎治疗的新方法。 TRM 是最近描述的长寿 T 细胞的子集(CD8 和 CD4),在皮肤中发育 和其他组织作为对组织炎症的反应,此后持续数年以提供 持久的位点特异性免疫。 TRM 从未在关节中被描述过。我们现在有 使用以下方法开发了令人信服的证据来证明这些细胞在人类关节炎滑膜中的存在 三种正交方法:单细胞 RNAseq,一种新型的 3 维滑膜培养系统, 结合飞行时间细胞计数 (CyTOF) 和 Mantra 多维 免疫荧光成像。此外,我们开发或调整了三种动物模型 开发新的小鼠系统,优化用于研究复发性、关节特异性、T 细胞依赖性 炎症性关节炎。 根据这些初步数据,我们提出了两个具体目标。首先,我们将执行一个 人类滑膜 TRM 在表面表型方面的综合表征, 介质、转录组和代谢来比较滑膜 TRM 与滑膜效应记忆 T 细胞和来自人体皮肤的“黄金标准”TRM。其次,我们将使用我们的动物模型 描述 TRM 随着时间的推移的发展和持续性;来测试这些的可能性 细胞可以在不依赖于抗原的触发以及抗原暴露下重新激活关节炎;和 采用局部耗竭来测试 TRM 靶向作为治疗持久性关节特异性关节炎的新方法 治疗。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Peter A Nigrovic其他文献

Development of consensus best treatment plans for new-onset systemic juvenile idiopathic arthritis
  • DOI:
    10.1186/1546-0096-10-s1-a50
  • 发表时间:
    2012-07-13
  • 期刊:
  • 影响因子:
    2.300
  • 作者:
    Esi M Morgan DeWitt;Timothy Beukelman;Peter A Nigrovic;Karen Onel;Sampath Prahalad;Rayfel Schneider;Matthew Stoll;Carol A Wallace;Yukiko Kimura
  • 通讯作者:
    Yukiko Kimura
Disease characteristics and medication use in a multicenter cohort of children with juvenile idiopathic arthritis (JIA): preliminary analyses from the CARRAnet registry
  • DOI:
    10.1186/1546-0096-10-s1-a46
  • 发表时间:
    2012-07-13
  • 期刊:
  • 影响因子:
    2.300
  • 作者:
    Sarah Ringold;Timothy Beukelman;Esi M Morgan DeWitt;Marc Natter;Peter A Nigrovic;Yukiko Kimura
  • 通讯作者:
    Yukiko Kimura
Juvenile idiopathic arthritis is associated with potentially pathogenic glycosylation of IgG
  • DOI:
    10.1186/1546-0096-10-s1-a5
  • 发表时间:
    2012-07-13
  • 期刊:
  • 影响因子:
    2.300
  • 作者:
    Altan Ercan;Melissa Hazen;Mary Beth Son;Susan Kim;Fatma Dedeoglu;Robert P Sundel;Robert C Fuhlbrigge;Jing Cui;Nancy A Shadick;Michael E Weinblatt;Michael Spigarelli;David N Glass;Susan D Thompson;Peter A Nigrovic
  • 通讯作者:
    Peter A Nigrovic

Peter A Nigrovic的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Peter A Nigrovic', 18)}}的其他基金

Impact of emperipolesis on platelet function
伸入对血小板功能的影响
  • 批准号:
    10705905
  • 财政年份:
    2022
  • 资助金额:
    $ 42.66万
  • 项目类别:
Modulation of neutrophil function through emperipolesis
通过伸入调节中性粒细胞功能
  • 批准号:
    10091401
  • 财政年份:
    2020
  • 资助金额:
    $ 42.66万
  • 项目类别:
Modulation of neutrophil function through emperipolesis
通过伸入调节中性粒细胞功能
  • 批准号:
    10656013
  • 财政年份:
    2020
  • 资助金额:
    $ 42.66万
  • 项目类别:
T resident memory cells in arthritis
关节炎中的 T 常驻记忆细胞
  • 批准号:
    10179324
  • 财政年份:
    2019
  • 资助金额:
    $ 42.66万
  • 项目类别:
T resident memory cells in arthritis
关节炎中的 T 常驻记忆细胞
  • 批准号:
    10609770
  • 财政年份:
    2019
  • 资助金额:
    $ 42.66万
  • 项目类别:
Bridging the gap between GWAS and mechanism in JIA
弥合 GWAS 和 JIA 机制之间的差距
  • 批准号:
    10064581
  • 财政年份:
    2018
  • 资助金额:
    $ 42.66万
  • 项目类别:
Bridging the gap between GWAS and mechanism in JIA
弥合 GWAS 和 JIA 机制之间的差距
  • 批准号:
    10675585
  • 财政年份:
    2018
  • 资助金额:
    $ 42.66万
  • 项目类别:
Bridging the gap between GWAS and mechanism in JIA
弥合 GWAS 和 JIA 机制之间的差距
  • 批准号:
    10622118
  • 财政年份:
    2018
  • 资助金额:
    $ 42.66万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10454987
  • 财政年份:
    2016
  • 资助金额:
    $ 42.66万
  • 项目类别:
Joint Biology Consortium Resource-based Center
联合生物学联盟资源中心
  • 批准号:
    10684880
  • 财政年份:
    2016
  • 资助金额:
    $ 42.66万
  • 项目类别:

相似海外基金

cGAS-STING Pathway Targeting Replicative Adenoviruses with CD46 Tropism and AFP Promoter Conditional Replication Restriction for the Treatment of Hepatocellular Carcinoma
cGAS-STING 通路靶向具有 CD46 趋向性和 AFP 启动子的复制腺病毒条件性复制限制用于治疗肝细胞癌
  • 批准号:
    10436626
  • 财政年份:
    2021
  • 资助金额:
    $ 42.66万
  • 项目类别:
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
  • 批准号:
    10557162
  • 财政年份:
    2021
  • 资助金额:
    $ 42.66万
  • 项目类别:
Molecular therapy of replication-competent adenoviruses targeting characteristic gene mutations found in mesothelioma
针对间皮瘤中发现的特征基因突变的具有复制能力的腺病毒的分子疗法
  • 批准号:
    21K08199
  • 财政年份:
    2021
  • 资助金额:
    $ 42.66万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
  • 批准号:
    10330464
  • 财政年份:
    2021
  • 资助金额:
    $ 42.66万
  • 项目类别:
Structural characterization of nucleoprotein cores of human adenoviruses
人腺病毒核蛋白核心的结构表征
  • 批准号:
    9807741
  • 财政年份:
    2019
  • 资助金额:
    $ 42.66万
  • 项目类别:
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
  • 批准号:
    41625-2013
  • 财政年份:
    2018
  • 资助金额:
    $ 42.66万
  • 项目类别:
    Discovery Grants Program - Individual
The therapeutic strategies with augmented replications of oncolytic adenoviruses for malignant mesothelioma
溶瘤腺病毒增强复制治疗恶性间皮瘤的治疗策略
  • 批准号:
    18K15937
  • 财政年份:
    2018
  • 资助金额:
    $ 42.66万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
  • 批准号:
    41625-2013
  • 财政年份:
    2017
  • 资助金额:
    $ 42.66万
  • 项目类别:
    Discovery Grants Program - Individual
Exploring the effects of nutrient deprivation on T cells and oncolytic adenoviruses, in order to create immune activators for tumour therapy
探索营养剥夺对 T 细胞和溶瘤腺病毒的影响,以创造用于肿瘤治疗的免疫激活剂
  • 批准号:
    1813152
  • 财政年份:
    2016
  • 资助金额:
    $ 42.66万
  • 项目类别:
    Studentship
Research on detection of novel adenoviruses by genetic methods
新型腺病毒的基因检测研究
  • 批准号:
    16K09118
  • 财政年份:
    2016
  • 资助金额:
    $ 42.66万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了